The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.80
Bid: 67.80
Ask: 68.00
Change: -0.20 (-0.29%)
Spread: 0.20 (0.295%)
Open: 67.80
High: 67.80
Low: 67.60
Prev. Close: 68.00
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PROPOSED INVESTMENT IN FETTLE TONE LLP

15 Mar 2021 07:00

RNS Number : 1837S
Axis Bank Limited
14 March 2021
 

AXIS/CO/CS/600/2020-21

 

14th March 2021

 

Dear Sir(s),

 

SUB: PROPOSED INVESTMENT IN FETTLE TONE LLP

 

REF: REGULATION 30 READ WITH PARA A OF PART A OF SCHEDULE III OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

 

We wish to inform you that Axis Bank Limited has entered into definitive agreements with Fettle Tone LLP and the other partners of Fettle Tone LLP on 13th March 2021 in connection with Axis Bank Limited's proposed acquisition of 9.90% of the aggregate partnership interest of Fettle Tone LLP pursuant to a contribution by Axis Bank Limited in Fettle Tone LLP's partnership capital.

 

The details as required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 are provided in Annexure A.

 

You are requested to take note of above and arrange to bring the same to the notice of all concerned.

 

Thanking you,

 

Yours faithfully,

For Axis Bank Limited

 

 

 

 

 

Girish V. Koliyote

Company Secretary

 

 

Encl: As above.

 

 

 

 

 

 

 

 

 

Annexure A

 

Details which a listed entity needs to disclose for the events that are deemed to be material as specified in Para A of Part A of Schedule III of Listing Regulations.

 

1. Acquisition(s) (including agreement to acquire), Scheme of Arrangement (amalgamation/ merger/ demerger/restructuring), or sale or disposal of any unit(s), division(s) or subsidiary of the listed entity or any other restructuring:

 

1.1. Acquisition (including agreement to acquire):

 

S. No.

Particulars

Details

a.

Name of the target entity, details in brief such as size, turnover etc.

Fettle Tone LLP

 

Net worth as of 31st March 2020 = Rs 607 cr

Turnover for financial year ended 31st March 2020= Rs. 0.16 cr

b.

Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length"

The transaction does not constitute a related party transaction. Axis Bank Limited's promoter / promoter group does not hold any interest in Fettle Tone LLP.

 

Axis Bank Limited and its subsidiaries may have business dealings with Fettle Tone LLP in the ordinary course of business and on an arm's length basis.

c.

Industry to which the entity being acquired belongs

Fettle Tone LLP is a special purpose vehicle (SPV) set up by True North Fund VI LLP under the IRDAI (Investment by Private Equity Funds in Indian Insurance Companies) Guidelines, 2017.

 

Fettle Tone LLP is currently a promoter of Max Bupa Health Insurance Company Limited ("MBHI") and holds ~55.6% of the total share capital of MBHI. MBHI is a standalone health insurance company registered with the Insurance Regulatory and Development Authority of India.

d.

Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)

To strengthen Axis Bank Limited's position in the insurance sector, pursuant to its investment in Fettle Tone LLP.

 

As mentioned above, Fettle Tone LLP is currently a promoter of MBHI and MBHI is a standalone health insurance company registered with the Insurance Regulatory and Development Authority of India.

e.

Brief details of any governmental or regulatory approvals required for the acquisition

None

f.

Indicative time period for completion of the acquisition

The definitive agreements in connection with the proposed acquisition have been executed by Axis Bank Limited on March 13, 2021 and the acquisition is proposed to be completed on or before March 17, 2021.

 

g.

Nature of consideration - whether cash consideration or share swap and details of the same

Cash consideration

h.

Cost of acquisition or the price at which the shares are acquired

Contribution of Rs 90.8 crores by Axis Bank Limited (in cash) in the partnership capital of Fettle Tone LLP for acquiring 9.90% of the aggregate partnership interest of Fettle Tone LLP

i.

Percentage of shareholding / control acquired and / or number of shares acquired

9.90% of the aggregate partnership interest of Fettle Tone LLP

j.

Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)

Line of business: Fettle Tone LLP is a special purpose vehicle (SPV) set up by True North Fund VI LLP under the IRDAI (Investment by Private Equity Funds in Indian Insurance Companies) Guidelines, 2017. It is currently a promoter of MBHI and holds ~55.6% of the total share capital of MBHI. MBHI is a standalone health insurance company registered with the Insurance Regulatory and Development Authority of India.

 

Date of Incorporation: Fettle Tone LLP was incorporated on 23 May 2019 as a limited liability partnership under the Limited Liability Partnership Act, 2008.

 

Turnover:

Financial year ended 31st March 2020 - Rs. 0.16 crores

Country of operation: India

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSRURABUOAAR
Date   Source Headline
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:53 amRNSRevision in Vesting Period - ESOS
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
15th Dec 20238:36 amRNSCessation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
22nd Nov 20232:22 pmRNSCredit Rating
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
1st Nov 20238:36 amRNSPostal Ballot Notice
26th Oct 20232:46 pmRNSPostal Ballot Voting Results
26th Oct 20231:35 pmRNSCessation
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
3rd Oct 20239:54 amRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
18th Aug 202311:17 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
28th Jul 20233:47 pmRNSVoting Results AGM
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.